700 Journals and 15,000,000 ReadersEach Journal is getting 25,000+ Readers
This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Integrative Approach to Biological Networks for Emerging Roles of
Proteomics, Genomics and Transcriptomics in the Discovery and Validation
of Human Colorectal Cancer Biomarkers from DNA/RNA Sequencing Data
under Synchrotron Radiation
Nano catalytic hydrogenation is the useful and widely applicable method for the reduction of chemical substances and belongs to the basic processes of modern medicinal and pharmaceutical chemistry. It has found numerous applications in biological networks for emerging roles of proteomics, genomics and transcriptomics in the discovery and validation of human colorectal cancer biomarkers from DNA/RNA sequencing data under synchrotron radiation. Majority of medicinal and pharmaceutical nano catalytic hydrogenations is still carried out using heterogeneous nano catalysts due to the process advantages such as ability, easy separation, and wide range of applicable reaction conditions. The homogenous nano catalysts, which have been further developed during the past years, have extended the scope of nano catalytic hydrogenation especially in the field of highly stereo selective transformations in biological networks for emerging roles of proteomics, genomics and transcriptomics in the discovery and validation of human colorectal cancer biomarkers from DNA/ RNA sequencing data under synchrotron radiation. However, new developments continue to appear also in the field of heterogeneous nano catalysis, particularly in cases where a high chemo-, region-, or stereo selectivity must be achieved.